40 results
8-K
EX-1.1
PHIO
Phio Pharmaceuticals Corp
19 Nov 19
Entry into a Material Definitive Agreement
9:29pm
and in connection with the transactions contemplated hereby, including, without limitation: (i) all expenses incident to the issuance, delivery … and exemptions (not to exceed $10,000 in the aggregate); (vii) if applicable, the filing fees incident to the review and approval by the FINRA
10-Q
2012 Q1
EX-3.2
PHIO
Phio Pharmaceuticals Corp
14 May 12
Quarterly report
12:00am
and control of the business and affairs of the Corporation and shall perform all duties and have all powers that are commonly incident to the office
8-K
EX-3.1
PHIO
Phio Pharmaceuticals Corp
13 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
that are commonly incident to the office of chief executive or which are delegated to him or her by the Board of Directors. He or she shall have the power to sign all
8-K
EX-3.1
PHIO
Phio Pharmaceuticals Corp
2 May 22
Changes in Control of Registrant
7:30am
management and control of the business and affairs of the Corporation and shall perform all duties and have all powers that are commonly incident
8-K
EX-3.3
PHIO
Phio Pharmaceuticals Corp
19 Nov 18
Departure of Directors or Certain Officers
12:00am
of the business and affairs of the Corporation and shall perform all duties and have all powers that are commonly incident to the office of chief
8-K
EX-10.2
au85w28y7jyyoos6
3 Jul 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
e8l7l5 7mruwlc21jrf9
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.2
5gd9d38xyc xywbaw5
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm
424B2
0mhnr5g7ido
9 Feb 21
Prospectus for primary offering
8:00am
424B3
jbncv
28 Dec 23
Prospectus supplement
9:13am
424B3
s9tas9fo75tet
20 Jun 23
Prospectus supplement
9:30am
424B3
r4xquu9hwvb lr82jg8o
2 Oct 19
Prospectus supplement
6:04pm